MyAverix Finance
SHG · Healthcare
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266)
Biotechnology
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $26.65B, P/E ratio is 18.00, net margin is -19.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688266
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) — FAQ
What is Suzhou Zelgen Biopharmaceuticals Co Ltd's market cap?
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a reported market cap of $26.65B (data as of 2026-03-29).
What is 688266's P/E ratio?
The price-to-earnings (P/E) ratio for Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) is 18.00 (data as of 2026-03-29).
Does Suzhou Zelgen Biopharmaceuticals Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Suzhou Zelgen Biopharmaceuticals Co Ltd (688266). Check the MyAverix Finance app for the latest dividend data.
What sector is Suzhou Zelgen Biopharmaceuticals Co Ltd in?
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688266 listed on?
688266 is listed on SHG.
What is Suzhou Zelgen Biopharmaceuticals Co Ltd's net margin?
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) reports a net margin of -19.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.